Richard Erwin
Neurology · Fredericksburg, VANPI 1073545794
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $757 and has fallen 97.7% since, to $17 in 2025. That places this record below the midpoint for neurology clinicians in VA, where the typical reported total is $1,288.
Across 72 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$228
- UCB, Inc.$121
- Novartis$88
- Lilly USA, LLC$69
- Sanofi Pasteur Inc.$68
- Sunovion Pharmaceuticals Inc.$67
- plus $620 from 18 others
What the payments were for
- Food & beverage$1,261100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $228 |
| UCB, Inc. | 6 | $121 |
| Novartis | 4 | $88 |
| Lilly USA, LLC | 4 | $69 |
| Sanofi Pasteur Inc. | 4 | $68 |
| Sunovion Pharmaceuticals Inc. | 8 | $67 |
| Medtronic | 1 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Sanofi | 3 | $60 |
| Biogen | 3 | $59 |
| AstraZeneca | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| EMD Serono, Inc. | 3 | $46 |
| Amgen(2 entities) | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $14 |
How this compares
$1,261 in reported general payments places this provider in the 45th percentile of 474 neurology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $899 |
| Levetiracetam | 18 | $530 |
Paid to pharmacies, not to this prescriber.
Other neurology in Fredericksburg
- Dale PcsolyarFredericksburg$49K
- Ramsey FalconerAlexandria$2M
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
- Jill CramerChristiansburg$598K
- Rahul DaveFairfax$540K
- Daniel HardyRichmond$382K
- Ingrid Loma MillerNorfolk$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.